Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.730
-0.010 (-0.36%)
At close: Sep 11, 2026, 4:00 PM EDT
2.779
+0.049 (1.81%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Cabaletta Bio Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Cabaletta Bio stock has a consensus rating of "Buy" and an average price target of $13.25. The average 1-year stock price forecast is 385.35% higher than the current stock price, while the lowest is $3.00 (+9.89%) and the highest is $30 (+998.90%).
Price Target: $13.25 (+385.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cabaletta Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 2, 2026 |
| Citi | Citi | Buy Maintains $10 | Buy | Maintains | $10 | +266.30% | Sep 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $16 | Buy | Maintains | $16 | +486.08% | Sep 2, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Reiterates $3 | Hold | Reiterates | $3 | +9.89% | Sep 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $13 | Buy | Reiterates | $13 | +376.19% | Aug 17, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.36
from -2.10
EPS Next Year
-1.48
from -1.36
EPS and Forward PE are based on non-GAAP adjusted numbers.